This map shows the geographic impact of Morris Re's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morris Re with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morris Re more than expected).
This network shows the impact of papers produced by Morris Re. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morris Re. The network helps show where Morris Re may publish in the future.
Co-authorship network of co-authors of Morris Re
This figure shows the co-authorship network connecting the top 25 collaborators of Morris Re.
A scholar is included among the top collaborators of Morris Re based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Morris Re. Morris Re is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Re, Morris, et al.. (1995). Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells.. PubMed. 27(1). 430–1.36 indexed citations
5.
Re, Morris. (1993). Commentary on new xenobiotic immunosuppressants for transplantation: Where are we, how did we get here, and where are we going?. PubMed. 7(1 part 2). 138–46.1 indexed citations
6.
Re, Morris, et al.. (1991). 15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.. Transplantation Proceedings. 23(1 Pt 1). 535–9.8 indexed citations
7.
Re, Morris, et al.. (1991). Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.. PubMed. 23(1 Pt 1). 521–4.53 indexed citations
8.
Re, Morris, et al.. (1991). Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.. PubMed. 23(2 Suppl 2). 19–25.69 indexed citations
9.
Re, Morris, et al.. (1991). Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.. PubMed. 23(1 Pt 1). 493–6.23 indexed citations
10.
Re, Morris, et al.. (1990). Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation.. PubMed. 22(1). 110–2.14 indexed citations
11.
Re, Morris, et al.. (1989). Immunopharmacology of FK-506.. Transplantation Proceedings. 21(1 Pt 1). 1042–4.10 indexed citations
12.
Re, Morris, et al.. (1987). A comparison of the in vitro and in vivo immunologic activities of concanavalin A and its succinylated derivative.. PubMed. 19(1 Pt 1). 626–7.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.